{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:32:36Z","timestamp":1741152756476,"version":"3.38.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01174-3","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:11:06Z","timestamp":1741083066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of HIV and Hepatitis C and access to opioid substitution treatment among people who inject drugs in three cities in Croatia: findings from the second wave of respondent-driven sampling surveys"],"prefix":"10.1186","volume":"22","author":[{"given":"Sandra","family":"\u0160evi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran","family":"Koleti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana Nemeth","family":"Bla\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana Lana","family":"Kosanovi\u0107 Li\u010dina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josipa-Lovorka","family":"Andrei\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senad","family":"Handanagi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda Pletikosa","family":"Pavi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Bo\u017ei\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"publisher","first-page":"102866","DOI":"10.1016\/j.drugpo.2020.102866","volume":"84","author":"LT Tran","year":"2020","unstructured":"Tran LT, Peacock A, Colledge S, Memedovic S, Grebely J, Leung J, et al. Injecting risk behaviours amongst people who inject drugs: a global multi-stage systematic review and meta-analysis. Int J Drug Policy. 2020;84:102866.","journal-title":"Int J Drug Policy"},{"issue":"Suppl 6","key":"1174_CR2","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2334-14-S6-S4","volume":"14","author":"C Ford","year":"2014","unstructured":"Ford C, Bressan J. Ending the mass criminalisation of people who use drugs: a necessary component of the public health response to hepatitis C. BMC Infect Dis. 2014;14(Suppl 6):S4.","journal-title":"BMC Infect Dis"},{"key":"1174_CR3","unstructured":"Health. Rights and drugs: harm reduction, decriminalization and zero discrimination for people who use drugs. Geneva: UNAIDS; 2019."},{"key":"1174_CR4","volume-title":"Sector strategies on HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030","author":"WHO Global health","year":"2022","unstructured":"WHO Global health. Sector strategies on HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. Geneva: World Health Organization; 2022."},{"key":"1174_CR5","unstructured":"European Drug Report. 2022: Trends and Developments. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, 2023."},{"key":"1174_CR6","volume-title":"Europe 2023\u20132022 data","author":"HIV\/AIDS surveillance in","year":"2023","unstructured":"HIV\/AIDS surveillance in. Europe 2023\u20132022 data. Stockholm: European Centre for Disease Prevention and Control\/WHO Regional Office for Europe; 2023."},{"key":"1174_CR7","unstructured":"Epidemiology of HIV and AIDS in Croatia. Croatian Institute for Public Health. Available at: Epidemiologija HIV infekcije i AIDS-a u hrvatskoj| Hrvatski Zavod Za javno zdravstvo (hzjz.hr). Accessed on 25 March 2024."},{"key":"1174_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugpo.2016.04.007","volume":"32","author":"S Handanagic","year":"2016","unstructured":"Handanagic S, Bozicevic I, Civljak M, Dominkovic Z, Sevic S, Barbaric J, et al. HIV and Hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: findings from respondent-driven sampling surveys. Int J Drug Policy. 2016;32:57\u201363.","journal-title":"Int J Drug Policy"},{"key":"1174_CR9","volume-title":"Croatia in 2022","author":"Report on persons treated for substance abuse in","year":"2023","unstructured":"Report on persons treated for substance abuse in. Croatia in 2022. Zagreb: Croatian Institute for Public Health; 2023. Croatian. In."},{"issue":"4 Suppl","key":"1174_CR10","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1007\/s10461-008-9421-1","volume":"2","author":"M Malekinejad","year":"2008","unstructured":"Malekinejad M, Kendall LG, LRF C, M GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;2(4 Suppl):S105\u201330.","journal-title":"AIDS Behav"},{"key":"1174_CR11","unstructured":"Handcock MS, Fellows IE, Gile KJ. RDS analyst: Software for the analysis of Respondent-driven Sampling Data. Version 0.86., 2012."},{"key":"1174_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1198\/jasa.2011.ap09475","volume":"106","author":"KJ Gile","year":"2011","unstructured":"Gile KJ. Improved inference for respondent-driven sampling data with application to HIV prevalence estimation. J Am Stat Assoc. 2011;106:135\u201346.","journal-title":"J Am Stat Assoc"},{"key":"1174_CR13","volume-title":"Release 17. College Station","author":"Stata Statistical Software","year":"2023","unstructured":"Stata Statistical Software. Release 17. College Station. TX: StataCorp LLC; 2023."},{"issue":"1","key":"1174_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1467-9531.2007.00188.x","volume":"37","author":"DD Heckathorn","year":"2007","unstructured":"Heckathorn DD. Extensions of respondent-driven sampling: analyzing continuous variables and controlling for differential recruitment. Sociol Meth. 2007;37(1):151\u2013208.","journal-title":"Sociol Meth"},{"key":"1174_CR15","volume-title":"Targets 2025 for people who use drugs: where are we now?","author":"AIDS Global","year":"2024","unstructured":"Global AIDS. Targets 2025 for people who use drugs: where are we now? Geneva: UNAIDS; 2024."},{"key":"1174_CR16","unstructured":"Viral hepatitis elimination barometer among people who inject drugs in Europe. Lisbon: The European Monitoring Centre for Drugs and Drug Addiction, 2023."},{"key":"1174_CR17","unstructured":"Croatian Health Insurance Fund. Indications and guidelines. In Croatian. Available at Indikacije smjernice NJ711 (hzzo.hr). Accessed on 28 March 2024."},{"key":"1174_CR18","volume-title":"Prevention and control of infectious diseases among people who inject drugs: 2023 update","author":"European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2023","unstructured":"European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevention and control of infectious diseases among people who inject drugs: 2023 update. Stockholm: ECDC; 2023."},{"issue":"5","key":"1174_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/COH.0000000000000179","volume":"10","author":"NK Martin","year":"2015","unstructured":"Martin NK, Vickerman P, Dore GJ, Hickman M. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention. Curr Opin HIV AIDS. 2015;10(5):374\u201380.","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"1174_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jhep.2017.10.010","volume":"68","author":"H Fraser","year":"2018","unstructured":"Fraser H, Martin NK, Brummer-Korvenkontio H, Carrieri P, Dalgard O, Dillon J, et al. Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. J Hepatol. 2018;68(3):402\u201311.","journal-title":"J Hepatol"},{"key":"1174_CR21","volume-title":"C to reach elimination by 2030","author":"Combating hepatitis B and","year":"2016","unstructured":"Combating hepatitis B and. C to reach elimination by 2030. Geneva: World Health Organization; 2016."},{"key":"1174_CR22","doi-asserted-by":"publisher","first-page":"103130","DOI":"10.1016\/j.drugpo.2021.103130","volume":"95","author":"TM Brunt","year":"2021","unstructured":"Brunt TM, Lefran\u00e7ois E, Gunnar T, Arponen A, Seyler T, Goudriaan AE, et al. Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: the European Syringe Collection and Analysis Project Enterprise (ESCAPE). Int J Drug Policy. 2021;95:103130.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1174_CR23","doi-asserted-by":"publisher","first-page":"e218049","DOI":"10.1001\/jamanetworkopen.2021.8049","volume":"4","author":"BS Bentzley","year":"2021","unstructured":"Bentzley BS, Neuner SH, Humphreys S, KM K. Comparison of treatments for Cocaine Use Disorder among adults: a systematic review and Meta-analysis. JAMA Netw Open. 2021;4(5):e218049.","journal-title":"JAMA Netw Open"},{"key":"1174_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1176\/ajp.2007.164.1.157","volume":"164","author":"ND Volkow","year":"2007","unstructured":"Volkow ND, Wang GJ, Fowler JS, Telang F, Jayne M, Wong C. Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am J Psychiatry. 2007;164:157\u201360.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1174_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00213-016-4493-5","volume":"234","author":"MW Johnson","year":"2017","unstructured":"Johnson MW, Hermann ES, Sweeney MM, LeComte RS, Johnson PS. Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: the role of delay and probability discounting in connecting cocaine with HIV. Psychopharmacology. 2017;234(4):599\u2013612.","journal-title":"Psychopharmacology"},{"issue":"5","key":"1174_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S2352-3018(19)30036-0","volume":"6","author":"A McAuley","year":"2019","unstructured":"McAuley A, Palmateer NE, Goldberg DJ, Trayner KMA, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6(5):315\u201324.","journal-title":"Lancet HIV"},{"issue":"6","key":"1174_CR27","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/add.15812","volume":"117","author":"S Roussos","year":"2022","unstructured":"Roussos S, Paraskevis D, Psichogiou M, Kostaki EG, Flountzi E, Angelopoulos T, et al. Ongoing HIV transmission following a large outbreak among people who inject drugs in Athens, Greece (2014-20). Addiction. 2022;117(6):1670\u201382.","journal-title":"Addiction"},{"issue":"5","key":"1174_CR28","doi-asserted-by":"publisher","first-page":"e0215570","DOI":"10.1371\/journal.pone.0215570","volume":"14","author":"V Arendt","year":"2019","unstructured":"Arendt V, Guillorit L, Origer A, Sauvageot N, Vaillant M, Fischer A, et al. Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg. PLoS ONE. 2019;14(5):e0215570.","journal-title":"PLoS ONE"},{"key":"1174_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0376-8716(94)90095-7","volume":"36","author":"CG Schutz","year":"1994","unstructured":"Schutz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injection drug users. Drug Alcohol Depend. 1994;36:129\u201338.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1174_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugalcdep.2005.10.015","volume":"83","author":"RA Pollini","year":"2006","unstructured":"Pollini RA, McCall L, Mehta SH, Vlahov D. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006;83(2):104\u201310.","journal-title":"Drug Alcohol Depend"},{"key":"1174_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugpo.2018.11.017","volume":"64","author":"S Handanagic","year":"2019","unstructured":"Handanagic S, Bozicevic I, Sekerija M, Rutherford GW, Begovac J. Overdose mortality rates in Croatia and factors associated with self-reported drug overdose among persons who inject drugs in three Croatian cities. Int J Drug Policy. 2019;64:95\u2013102.","journal-title":"Int J Drug Policy"},{"key":"1174_CR32","doi-asserted-by":"crossref","unstructured":"Gogia M, Ruadze E, Kasrashvili T, Mathers B, Sabin K, Verster A et al. Piloting a simplified bio-behavioural survey methodology, the BBS-Lite, among people who inject drugs in Georgia. Int J Drug Policy. 2024:104326.","DOI":"10.1016\/j.drugpo.2024.104326"},{"issue":"1","key":"1174_CR33","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1186\/s12889-016-3887-y","volume":"16","author":"V Akbarzadeh","year":"2016","unstructured":"Akbarzadeh V, Mumtaz GR, Awad SF, Weiss HA, Abu-Raddad LJ. HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis. BMC Public Health. 2016;16(1):1216.","journal-title":"BMC Public Health"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01174-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:11:13Z","timestamp":1741083073000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01174-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01174-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical Approval was granted by the Ethical Board of the Croatian National Institute of Public Health. All study participants were explained the purpose and the process of the survey, were given to read an informed consent form and provided an oral consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript does not contain any individual person\u2019s data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}